BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34437837)

  • 21. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medulloblastoma-associated mutations in the DEAD-box RNA helicase DDX3X/DED1 cause specific defects in translation.
    Brown NP; Vergara AM; Whelan AB; Guerra P; Bolger TA
    J Biol Chem; 2021; 296():100296. PubMed ID: 33460649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.
    Phung B; Cieśla M; Sanna A; Guzzi N; Beneventi G; Cao Thi Ngoc P; Lauss M; Cabrita R; Cordero E; Bosch A; Rosengren F; Häkkinen J; Griewank K; Paschen A; Harbst K; Olsson H; Ingvar C; Carneiro A; Tsao H; Schadendorf D; Pietras K; Bellodi C; Jönsson G
    Cell Rep; 2019 Jun; 27(12):3573-3586.e7. PubMed ID: 31216476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of the DDX3Y gene and its homologs in cattle.
    Liu WS; Wang A; Yang Y; Chang TC; Landrito E; Yasue H
    Cytogenet Genome Res; 2009; 126(4):318-28. PubMed ID: 20016128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
    Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
    J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.
    Li S; Desai P; Lin P; Yin CC; Tang G; Wang XJ; Konoplev SN; Khoury JD; Bueso-Ramos CE; Medeiros LJ
    Histopathology; 2016 Jun; 68(7):1090-8. PubMed ID: 26426741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 29. Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.
    den Hollander J; Rimpi S; Doherty JR; Rudelius M; Buck A; Hoellein A; Kremer M; Graf N; Scheerer M; Hall MA; Goga A; von Bubnoff N; Duyster J; Peschel C; Cleveland JL; Nilsson JA; Keller U
    Blood; 2010 Sep; 116(9):1498-505. PubMed ID: 20519624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kindlin-2 enhances c-Myc translation through association with DDX3X to promote pancreatic ductal adenocarcinoma progression.
    Liu C; Jiang K; Ding Y; Yang A; Cai R; Bai P; Xiong M; Fu C; Quan M; Xiong Z; Deng Y; Tian R; Wu C; Sun Y
    Theranostics; 2023; 13(13):4333-4355. PubMed ID: 37649609
    [No Abstract]   [Full Text] [Related]  

  • 32. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
    Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
    Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis.
    Sabò A; Kress TR; Pelizzola M; de Pretis S; Gorski MM; Tesi A; Morelli MJ; Bora P; Doni M; Verrecchia A; Tonelli C; Fagà G; Bianchi V; Ronchi A; Low D; Müller H; Guccione E; Campaner S; Amati B
    Nature; 2014 Jul; 511(7510):488-492. PubMed ID: 25043028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas.
    Seegmiller AC; Garcia R; Huang R; Maleki A; Karandikar NJ; Chen W
    Mod Pathol; 2010 Jul; 23(7):909-20. PubMed ID: 20348878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion.
    Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Viral Protein K7 Inhibits Biochemical Activities and Condensate Formation by the DEAD-box Helicase DDX3X.
    Venus S; Tandjigora K; Jankowsky E
    J Mol Biol; 2023 Oct; 435(19):168217. PubMed ID: 37517790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DEAD-Box Helicase 3 X-Linked Promotes Metastasis by Inducing Epithelial-Mesenchymal Transition via p62/Sequestosome-1.
    Zheng Y; Xu B; Zhao Y; Yang S; Wang S; Ma L; Dong L
    Dig Dis Sci; 2021 Nov; 66(11):3893-3902. PubMed ID: 33386519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
    Lu Y; Wu Y; Feng X; Shen R; Wang JH; Fallahi M; Li W; Yang C; Hankey W; Zhao W; Ganju RK; Li MO; Cleveland JL; Zou X
    J Clin Invest; 2014 Apr; 124(4):1672-84. PubMed ID: 24614102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bptf determines oncogenic addiction in aggressive B-cell lymphomas.
    Richart L; Felipe I; Delgado P; Andrés MP; Prieto J; Pozo ND; García JF; Piris MA; Ramiro A; Real FX
    Oncogene; 2020 Jun; 39(25):4884-4895. PubMed ID: 32451433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.